BIIB vs IOVA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BIIB Captures Institutional Edge (3โ1 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biogen Inc. Common Stock (BIIB) driven by superior Valuation, Growth & Margin, Options & Structure while IOVA counters with relative strength in Momentum & Technical. Fundamentally, BIIB trades at 15.6x Forward P/E with 23.5% operating margin (+10.6% YoY revenue) versus IOVA at N/M Forward P/E and -60.8% operating margin (+80.1% YoY). In options structure, BIIB sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against IOVA sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | BIIB Revenue | IOVA Revenue | BIIB Op. Margin | IOVA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $13.4B | N/A | 43.8% | N/A | BIIB |
| FY2019 | $14.4B | N/A | 49.0% | N/A | BIIB |
| FY2020 | $13.4B | N/A | 33.8% | N/A | BIIB |
| FY2021 | $11.0B | N/A | 25.9% | N/A | BIIB |
| FY2022 | $10.2B | N/A | 29.9% | N/A | BIIB |
| FY2023 | $9.84B | $0M | 11.8% | -38735.0% | BIIB |
| FY2024 | $9.68B | $160M | 16.9% | -240.9% | BIIB |
| FY2025 | $9.89B | $260M | 13.1% | -153.1% | BIIB |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BIIB | IOVA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $37.0B | $3.5B | Larger Scale | BIIB |
| Trailing P/E Ratio Valuation | 109.9x | N/M | Lower Multiple | BIIB |
| Forward P/E Ratio Valuation | 15.6x | N/M | Lower Multiple | BIIB |
| Revenue Growth (YoY) Growth | +10.6% | +80.1% | Higher Growth | IOVA |
| Operating Margin (TTM) Profitability | 23.5% | -60.8% | Higher Margin | BIIB |
| Net Profit Margin Profitability | 3.4% | -58.2% | Higher Margin | BIIB |
| Return on Equity (ROE) Capital Efficiency | 1.9% | -29.1% | Higher ROE | BIIB |
| 52-Week Range Position Momentum | 92% ($160โ$261) | 42% ($2โ$15) | Stronger Trend | BIIB |
| Beta / 30D Volatility Risk Regime | 0.27ฮฒ ยท 36% Vol | 1.58ฮฒ ยท 144% Vol | Lower Realized Risk | BIIB |
| Unified Institutional Score Composite Signal | 50.2 / 100 (HOLD) | 70.4 / 100 (BUY) | Higher Composite | IOVA |